Given that knockout EGFR can improve the sensitivity of HCC cells to Lenvatinib in HCC cells [20], we utilized CRISPR and RNAi to alter DDX20 transcript levels and then to observe EGFR gene effect on HCC cell, which is implemented in the DepMap database. This evidence concerns the gene EGFR and hepatocellular carcinoma.